SCHEMBL31437201

SCHEMBL31437201

CC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
RAMP3 O60896 7/20 0.51
CALCR P30988 7/20 0.51
EPHA2 P29317 3/20 0.49
OPRM1 P35372 6/20 0.48
OPRK1 P41145 6/20 0.48
CTSL P07711 3/20 0.46
CTSS P25774 3/20 0.46
CTSK P43235 3/20 0.46
CTSH P09668 1/20 0.46
CXCR4 P61073 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31437169 0.95 OPRM1 (0.52) RAMP3CALCREPHA2OPRM1OPRK1
SCHEMBL31437175 0.95 OPRM1 (0.49) RAMP3CALCREPHA2OPRM1OPRK1
SCHEMBL31416058 0.89 RAMP3 (0.52) RAMP3CALCREPHA2OPRM1OPRK1
SCHEMBL31186832 0.89 EPHA2 (0.50) RAMP3CALCREPHA2
SCHEMBL31416061 0.88 RAMP3 (0.51) RAMP3CALCREPHA2OPRM1OPRK1
SCHEMBL32677400 0.87 CXCR4 (0.47) RAMP3CALCREPHA2OPRM1OPRK1
SCHEMBL32677398 0.87 CXCR4 (0.47) RAMP3CALCREPHA2OPRM1OPRK1
SCHEMBL32677417 0.87 CXCR4 (0.47) RAMP3CALCREPHA2OPRM1OPRK1
SCHEMBL7789924 0.86 OPRM1 (0.48) EPHA2OPRM1OPRK1CXCR4
SCHEMBL31437212 0.86 RAMP3 (0.50) RAMP3CALCREPHA2OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025037992-A1 NEW PEPTIDES AND USE THEREOF MAJEWSKI FILIP (PL) 2025-02-20 WO claimed
WO-2025037993-A1 DOSAGE FORM FOR PEPTIDE AGENTS MAJEWSKI FILIP (PL) 2025-02-20 WO disclosed
WO-2025037992-A1 NEW PEPTIDES AND USE THEREOF MAJEWSKI FILIP (PL) 2025-02-20 WO disclosed